Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 19, 1995 - Issue 6
18
Views
19
CrossRef citations to date
0
Altmetric
Original Article

Molecular Basis of A-Thalassa in Portugal

, , , , , , & show all
Pages 343-352 | Received 16 May 1995, Accepted 28 Aug 1995, Published online: 07 Jul 2009
 

Abstract

We have estimated the incidence and molecular basis of α-thal-assemia in a Portuguese population, mostly from the Greater Lisbon area. In a group of 100 consecutive cord blood samples, the gene frequency of the rightward deletion (-α3.7) was 0.035, and the leftward deletion (-α4.2) was 0.015. In this group, we have also found four heterozygotes for the triple α-globin gene rearrangement (αααanti3.7 gene frequency 0.020). We have characterized the subtypes of -α3.7 and αααanti3.7 rearrangements. On the whole, these results give an incidence of 10% for deletional a-thalassemia carriers in the studied Portuguese population In a group of 342 subjects presenting β-thalassemia, or Hb S trait, β-thalassemia major, sickle cell disease or low red blood cell indices, the -α3.7, -α4.2, –SEAMED (αα)MM and αααanti3.7 haplotypes were found in different combinations. Only one nondeletional α-thalassemia determinant (a 5 nucleotide deletion in the α2-globin gene in the second intervening sequence donor site) was detected, which might suggest a low incidence of these defects in the Portuguese population

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.